Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Effect of Person-Centered Occupational Therapy Interventions for Substance Use Disorder

NCT07364240 · tracked via the Priya Life Science Turkey tracker
Phase
Not applicable
Started
2026-01-27
Last updated
2026-01-28

Condition(s) studied

Substance Use Disorder (SUD)

Investigational drug(s) / intervention(s)

Awareness TrainingPerson-Centered Occupational Therapy

Awareness Training: A single-session educational program designed to increase awareness about the consequences of substance use and the recovery process.

Person-Centered Occupational Therapy: An 8-week person-centered program (3 sessions per week) focusing on daily life activities, productivity, and leisure goals identified through the COPM.

Study summary

This study investigates the impact of person-centered occupational therapy interventions on individuals diagnosed with substance use disorder. Substance use often leads to isolation and difficulties in daily activities such as work, self-care, and leisure time. The research aims to evaluate how a tailored 8-week therapy program affects participants' occupational performance, self-efficacy, and psychological resilience. Participants will be divided into a study group receiving therapy and a control group.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Being diagnosed with substance use disorder according to DSM-5 criteria. * Having completed the detoxification process. * Being between the ages of 18-65. * Having at least a primary school education. * Volunteering to participate and signing the informed consent. Exclusion Criteria: * Being in an acute psychotic episode. * Having severe neurological deficits that prevent responding to assessments. -Having severe visual or hearing loss that prevents completing the test batteries

Primary outcome measure(s)

  • Canadian Occupational Performance Measure (COPM) — Change from baseline at 8 weeks.
    A semi-structured interview used to identify and prioritize everyday activities that the individual finds difficult to perform. It measures two components: Occupational Performance and Satisfaction. Both are scored on a scale of 1 to 10, where higher scores indicate better performance and higher satisfaction.

Trial sites (1)

FacilityCityRegionStatus
Erenköy Mental and Neurological Diseases Training and Research Hospital Istanbul Turkey (Türkiye) Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07364240 on ClinicalTrials.gov ↗ ← All trials in Turkey